𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs)

✍ Scribed by Chao Wan; Qiling He; Mervyn McCaigue; David Marsh; Gang Li


Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
303 KB
Volume
24
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

To obtain enough quantity of osteogenic cells is a challenge for successful cell therapy in bone defect treatment, and cell numbers were usually achieved by culturing bone marrow cells in a relatively long duration. This study reports a simple and cost‐effective method to enhance the number of mesenchymal stem cells (MSCs) by collecting and replating the nonadherent cell population of marrow MSCs culture. Bone marrow MSCs were isolated from 11 patients, cultured at a density of 1 × 10^5^/cm^2^ to 1 × 10^6^/cm^2^ in flasks. For the first three times of media change, the floating cells were centrifuged and replated in separate flasks. The total number of cells in both the primary and replating flasks were counted at day 21. Cell proliferation rate, potentials for osteogenic, chondrognenic, and adipogenic differentiation were examined in both cell types in vitro. In vivo osteogenic potentials of the cells were also tested in mice implantation model. The results showed that MSCs derived from nonadherent cell population of marrow cell cultures have similar cell proliferation and differentiation potentials as the originally attached MSCs in vitro. When implanted with hydroxyapatite/tricalcium phosphate (HA‐TCP) materials subcutaneously in serve combined immune deficiency (SCID) mice, newly formed bony tissues were found in both cell type groups with osteocalcin expression. We have obtained 36.6% (20.70%–44.97%) more MSCs in the same culture period when the nonadherent cell populations were collected. The findings confirmed that the nonadherent cell population in the bone marrow culture is a complementary source of MSCs, collecting these cells is a simple and cost‐effective way to increase MSCs numbers and reduce the time required for culturing MSCs for clinical applications. Β© 2005 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res


πŸ“œ SIMILAR VOLUMES


Chondrogenesis of human bone marrow-deri
✍ Charles Huang, C.-Y. ;Reuben, Paul M. ;D'Ippolito, Gianluca ;Schiller, Paul C. ; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 567 KB

## Abstract Mesenchymal stem cells derived from human bone marrow (hBM‐MSCs) can differentiate into chondrogenic cells for the potential treatment of injured articular cartilage. To evaluate agarose gels as a supportive material for chondrogenesis of hBM‐MSCs, this study examined chondrogenesis of

Importance of serum source for the in vi
✍ Shivali Duggal; Jan E. Brinchmann πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 612 KB

## Abstract Human mesenchymal stem cells (hMSCs) may be used for therapeutic applications. Culture conditions such as the serum source may impact on cell quality and the onset of replicative senescence. We have examined the effect of culturing hMSCs in autologous serum (AS) versus fetal bovine seru